Skip to content

AOCI at other companies

AbbVie logo
AbbVieABBV
-$1.15B+33.8%
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
$444K+971%
Viking Therapeutics logo
Viking TherapeuticsVKTX
-$856K-296%
Arvinas logo
ArvinasARVN
-$400K-127%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
-$269K-416%
Arcus Biosciences logo
Arcus BiosciencesRCUS
-$1M

Other financials

Income statement

See full
Revenue-
Operating income-$22.5M-115%
Net income-$21.6M-132%
EPS (diluted)-$0.99-39.4%

Balance sheet

See full
Cash & equivalents$62.4M+136%
Total debt$336.0K-53.7%
Total equity$87.0M-42.3%
Total assets$98.6M-37.2%

Cash flow

See full
Operating cash flow-$18.9M-65.7%
CapEx--100%
Free cash flow-$16.8M-117%

Valuation

See full
Market cap$124.35M-58.6%
Enterprise value$62.25M-77.4%

Returns & leverage

See full
Return on equity-58.8%
Debt / equity0.0×
Current ratio8.1×-17.8×

Where this comes from

Reported directly by AARD in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: AARD’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about AARD's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AARD's AOCI?
AARD (AARD) reported AOCI of $14K in Q1 2026.
How has AARD's AOCI changed year-over-year?
AARD's AOCI decreased by 68.2% year-over-year, from $44K to $14K.
What does AOCI mean?
Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.